Header Logo

Connection

MARIA SUAREZ-ALMAZOR to Adult

Back to Details
This is a "connection" page, showing publications MARIA SUAREZ-ALMAZOR has written about Adult.
MARIA SUAREZ-ALMAZOR
Connection Strength
0.751
Adult
  1. Smoking cessation patterns, usefulness of quitting methods, and tobacco cessation motivators and barriers to quit in patients with rheumatoid arthritis. Clin Rheumatol. 2023 Aug; 42(8):2053-2068.
    View in: PubMed
    Score: 0.036
  2. Cervical Cancer Screening in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2021 12; 73(12):1796-1803.
    View in: PubMed
    Score: 0.032
  3. Randomized Controlled Trial of Patient Education Tools for Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 10; 73(10):1470-1478.
    View in: PubMed
    Score: 0.032
  4. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Arthritis Rheumatol. 2021 05; 73(5):866-874.
    View in: PubMed
    Score: 0.031
  5. Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis. Immunotherapy. 2021 04; 13(6):465-475.
    View in: PubMed
    Score: 0.031
  6. Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors. Cancer Immunol Immunother. 2021 Jul; 70(7):1939-1949.
    View in: PubMed
    Score: 0.031
  7. Interactions and perceptions of patients with rheumatoid arthritis participating in an online support group. Clin Rheumatol. 2020 Jun; 39(6):1775-1782.
    View in: PubMed
    Score: 0.029
  8. Evidence that Swimming May Be Protective of Knee Osteoarthritis: Data from the Osteoarthritis Initiative. PM R. 2020 06; 12(6):529-537.
    View in: PubMed
    Score: 0.028
  9. Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study. Clin Rheumatol. 2018 Jul; 37(7):1791-1797.
    View in: PubMed
    Score: 0.025
  10. Prospective cohort study of cancer patients diagnosed with incidental venous thromboembolism on routine computed tomography scans. Support Care Cancer. 2017 05; 25(5):1571-1577.
    View in: PubMed
    Score: 0.023
  11. Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports. PLoS One. 2016; 11(7):e0160221.
    View in: PubMed
    Score: 0.022
  12. Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer. 2013 Nov 09; 13:534.
    View in: PubMed
    Score: 0.019
  13. Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes. J Rheumatol. 2013 Aug; 40(8):1337-43.
    View in: PubMed
    Score: 0.018
  14. Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. Arthritis Rheum. 2013 Jun; 65(6):1421-9.
    View in: PubMed
    Score: 0.018
  15. Attitudes toward hepatitis B virus among Vietnamese, Chinese and Korean Americans in the Houston area, Texas. J Community Health. 2012 Oct; 37(5):1091-100.
    View in: PubMed
    Score: 0.017
  16. Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study. BMJ Support Palliat Care. 2012 Dec; 2(4):344-50.
    View in: PubMed
    Score: 0.017
  17. Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model. J Clin Oncol. 2011 Jun 01; 29(16):2240-6.
    View in: PubMed
    Score: 0.016
  18. Problems in transition and quality of care: perspectives of breast cancer survivors. Support Care Cancer. 2011 Dec; 19(12):1921-9.
    View in: PubMed
    Score: 0.015
  19. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol. 2010 Sep; 29(9):947-55.
    View in: PubMed
    Score: 0.015
  20. New understanding and approaches to treatment in rheumatoid arthritis. Br Med Bull. 2010; 94:201-14.
    View in: PubMed
    Score: 0.014
  21. Medical care of hepatitis B among Asian American populations: perspectives from three provider groups. J Gen Intern Med. 2010 Mar; 25(3):220-7.
    View in: PubMed
    Score: 0.014
  22. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2008 Jul; 27(7):883-9.
    View in: PubMed
    Score: 0.012
  23. Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol. 2007 Aug; 34(8):1718-26.
    View in: PubMed
    Score: 0.012
  24. Racial/ethnic differences in preferences for total knee replacement surgery. J Clin Epidemiol. 2006 Oct; 59(10):1078-86.
    View in: PubMed
    Score: 0.011
  25. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 2006 Jun 15; 55(3):385-93.
    View in: PubMed
    Score: 0.011
  26. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis. Med Decis Making. 2005 Nov-Dec; 25(6):655-66.
    View in: PubMed
    Score: 0.011
  27. Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease. J Rheumatol. 2005 May; 32(5):913-9.
    View in: PubMed
    Score: 0.010
  28. Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer. 2004 Sep 01; 101(5):1090-8.
    View in: PubMed
    Score: 0.010
  29. Ethnic differences in health preferences: analysis using willingness-to-pay. J Rheumatol. 2004 Sep; 31(9):1811-8.
    View in: PubMed
    Score: 0.010
  30. OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments. Semin Arthritis Rheum. 2024 Apr; 65:152344.
    View in: PubMed
    Score: 0.009
  31. Determinants of function after total knee arthroplasty. Phys Ther. 2003 Aug; 83(8):696-706.
    View in: PubMed
    Score: 0.009
  32. Stem cell transplantation for systemic sclerosis. Cochrane Database Syst Rev. 2022 07 29; 7:CD011819.
    View in: PubMed
    Score: 0.009
  33. Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation. J Immunother Cancer. 2021 02; 9(2).
    View in: PubMed
    Score: 0.008
  34. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis. J Manag Care Spec Pharm. 2021 01; 27(1):73-83.
    View in: PubMed
    Score: 0.008
  35. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
    View in: PubMed
    Score: 0.007
  36. Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature. J Immunother Cancer. 2019 11 21; 7(1):319.
    View in: PubMed
    Score: 0.007
  37. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. PLoS Med. 2019 05; 16(5):e1002800.
    View in: PubMed
    Score: 0.007
  38. Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer. 2019 04 16; 7(1):106.
    View in: PubMed
    Score: 0.007
  39. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. J Immunother Cancer. 2019 01 06; 7(1):2.
    View in: PubMed
    Score: 0.007
  40. Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol. 1998 Nov; 37(11):1215-9.
    View in: PubMed
    Score: 0.007
  41. Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review. Lancet Haematol. 2018 Oct; 5(10):e474-e478.
    View in: PubMed
    Score: 0.007
  42. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018 06 10; 36(17):1714-1768.
    View in: PubMed
    Score: 0.006
  43. Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant. Biol Blood Marrow Transplant. 2018 05; 24(5):1094-1098.
    View in: PubMed
    Score: 0.006
  44. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
    View in: PubMed
    Score: 0.006
  45. Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs. 2018 08; 36(4):601-607.
    View in: PubMed
    Score: 0.006
  46. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer. 2017 Sep 01; 123(17):3367-3376.
    View in: PubMed
    Score: 0.006
  47. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 05 08; 5:CD012657.
    View in: PubMed
    Score: 0.006
  48. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken). 2016 08; 68(8):1195-200.
    View in: PubMed
    Score: 0.006
  49. Development of an "Impact of HIV" Instrument for HIV Survivors. J Assoc Nurses AIDS Care. 2015 Nov-Dec; 26(6):720-31.
    View in: PubMed
    Score: 0.005
  50. HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract. 2015 Sep; 11(5):384-90.
    View in: PubMed
    Score: 0.005
  51. Effect of a clinic-wide social marketing campaign to improve adherence to antiretroviral therapy for HIV infection. AIDS Behav. 2013 Jan; 17(1):104-12.
    View in: PubMed
    Score: 0.004
  52. Performance of risk indices for identifying low bone mineral density and osteoporosis in Mexican Mestizo women with rheumatoid arthritis. J Rheumatol. 2012 Feb; 39(2):247-53.
    View in: PubMed
    Score: 0.004
  53. Development and validation of a case ascertainment tool for ankylosing spondylitis. Arthritis Care Res (Hoboken). 2010 Jan 15; 62(1):19-27.
    View in: PubMed
    Score: 0.004
  54. Doctor-patient interactions in Mexican patients with rheumatic disease. J Clin Rheumatol. 2009 Apr; 15(3):120-3.
    View in: PubMed
    Score: 0.003
  55. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007 Jun 01; 44(11):1493-9.
    View in: PubMed
    Score: 0.003
  56. Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med. 2006 Jun; 21(6):613-7.
    View in: PubMed
    Score: 0.003
  57. The population effectiveness of highly active antiretroviral therapy: are good drugs good enough? Curr HIV/AIDS Rep. 2005 Nov; 2(4):177-83.
    View in: PubMed
    Score: 0.003
  58. Ankylosing spondylitis of juvenile onset: comparison with adult onset disease. Scand J Rheumatol. 1983; 12(3):246-8.
    View in: PubMed
    Score: 0.002
  59. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000 Mar 27; 160(6):861-8.
    View in: PubMed
    Score: 0.002
  60. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer. 1999 Jul 01; 86(1):170-6.
    View in: PubMed
    Score: 0.002
  61. Age, pain intensity, and opioid dose in patients with advanced cancer. Cancer. 1998 Sep 15; 83(6):1244-50.
    View in: PubMed
    Score: 0.002
  62. Ossification of the posterior longitudinal ligament in three geographically and genetically different populations of ankylosing spondylitis and other spondyloarthropathies. Ann Rheum Dis. 1998 Jul; 57(7):429-33.
    View in: PubMed
    Score: 0.002
  63. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol. 1996 Jul-Aug; 14(4):373-9.
    View in: PubMed
    Score: 0.001
  64. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation. 1996 Apr 15; 61(7):1047-53.
    View in: PubMed
    Score: 0.001
  65. Low tear production in patients with diabetes mellitus is not due to Sj?gren's syndrome. Clin Exp Rheumatol. 1994 Jul-Aug; 12(4):375-80.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.